27064-00-2

Basic information

• Product Name: 1-chloro-2-(2-nitrophenoxy)benzene
• Synonyms: 1-chloro-2-(2-nitrophenoxy)benzene
• CAS NO: 27064-00-2
• Molecular Formula: C₁₂H₈ClNO₃
• Molecular Weight: 249.64982
• EINECS: -0
• Mol File: 27064-00-2.mol

Chemical Properties

• Melting Point: 48 °C
• Boiling Point: 209 °C(Press: 9 Torr)
• Appearance: /
• Density: 1.358±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-chloro-2-(2-nitrophenoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-chloro-2-(2-nitrophenoxy)benzene(27064-00-2)
• EPA Substance Registry System: 1-chloro-2-(2-nitrophenoxy)benzene(27064-00-2)

Safety Data

• Hazardous Substances Data: 27064-00-2(Hazardous Substances Data)

Usage

Type of compound

Organic compound

Derivative

Chlorinated derivative of 2-(2-nitrophenoxy)benzene

Usage

Intermediate in the synthesis of other organic compounds

Physical form

Pale yellow solid

Molecular weight

247.65 g/mol

Natural occurrence

Not naturally occurring

Synthesis

Typically synthesized in a laboratory setting

Health and environment hazards

Considered hazardous to human health and the environment

Upstream product

• 95-57-8 2-monochlorophenol 
• 88-73-3 2-Chloronitrobenzene 
• 17186-79-7 2-chlorophenyl methanesulfonate 
• 1493-27-2 ortho-nitrofluorobenzene 

Downstream Products

• 56966-47-3 2-(2-chlorophenoxy)aniline 
• 859186-52-0 (2-chloro-4-nitro-phenyl)-(2-nitro-phenyl)-ether 
• 95-57-8 2-monochlorophenol 
• 2592-95-2 benzotriazol-1-ol 
• 873977-74-3 N -(2-(2-chlorophenoxy)phenyl)acetamide 
• 873386-12-0 acetic acid-[2-(2-chloro-phenoxy)-4-nitro-anilide] 
• 860745-37-5 acetic acid-[2-(2-chloro-4-nitro-phenoxy)-4-nitro-anilide] 
• 135-67-1 phenoxazine 

Relevant articles and documents

Microwave assisted rapid synthesis of phenoxazines and benzopyridoxazines

A facile protocol for the synthesis of phenoxazines and benzopyridoxazines by Smiles rearrangement have been demonstrated in short reaction time under microwave irradiation. The control experiments suggest that a reaction proceeds through Smiles rearrangement followed SNAr ring closure by in situ cascade process. In our present work, both the electron donating and electron withdrawing groups were tolerant and provided a corresponding phenoxazine/benzopyridoxazine in good to moderate yields.

Synthesis of Cycloheptatrienes, Oxepines, Thiepines, and Silepines: A Comparison between Br?nsted Acid and Au-Catalysis

The cyclization of 1-(benzyl-, oxyaryl-, thioaryl-, and silaaryl)-2-ethynylbenzenes under Br?nsted acid- and Au(I)-catalysis is described. Br?nsted acid catalysis favors without exception the formation of the products derived from the regioselective proto

Design, synthesis and antifungal activity of novel furancarboxamide derivatives

Twenty-seven novel furancarboxamide derivatives with a diphenyl ether moiety were synthesized and evaluated for their antifungal activity against Rhizoctonia solani, Botrytis cirerea, Valsa Mali and Sphaceloma ampelimum. Antifungal bioassay results indicated that most compounds had good or excellent fungicidal activities for R. solani and S. ampelimum at 20 mg L-1. Among synthesized compounds, compound 18e showed a greater inhibitory effect against S. ampelimum, with half maximal effective concentration (EC50) values of 0.020 mg L-1. This strong activity rivals currently used commercial fungicides, such as Boscalid and Carbendazim, and has great potential as a lead compound for future development of novel fungicides.

DIARYL SUBSTITUTED HETEROAROMATIC COMPOUNDS

The invention relates to heterocyclic derivatives, to the use of said derivatives in treating a range of metabolic diseases and other conditions mediated by agonism of the G-protein coupled bile acid GPBAR1/TGR5 receptor, to compositions and formulations containing said derivatives, processes for their preparation and methods of delivery.

Synthesis and enantioselective hydrogenation of seven-membered cyclic imines: Substituted dibenzo[b,f][1,4]oxazepines

Highly enantioselective hydrogenation of seven-membered cyclic imines, substituted dibenzo[b,f][1,4]oxazepines, was achieved, with up to 94% ee, by using the [Ir(COD)Cl]2/(S)-Xyl-C3*-TunePhos complex as the catalyst in the presence of morpholine-HCl.

Microwave-assisted construction of diaryl ethers directly from arylmethanesulfonates as convenient latent phenols with aryl halides

The microwave-assisted synthesis of diaryl ethers directly from aryl halides and arylmethanesulfonates, which as latent phenols obviate a deprotection step prior to the SNAr reaction, in the presence of Cs2CO3 is described. The reaction time was very short (6-9-min), and good to excellent yields (53-90%) with the wide substrate scope were achieved without any catalyst. Copyright Taylor & Francis Group, LLC.

C(aryl)-O bond formation from aryl methanesulfonates via consecutive deprotection and SNAr reactions with aryl halides in an ionic liquid

An efficient K3PO4-mediated synthesis of unsymmetrical diaryl ethers using the ionic liquid [Bmim]BF4 (1-butyl-3-methylimidazolium tetrafluoroborate) as solvent has been developed. The procedure involves consecutive deprotection of aryl methanesulfonates and a nucleophilic aromatic substitution (SNAr) with activated aryl halides.

One-pot microwave-assisted tandem deprotection of arylmethanesulfonates / SNAr reaction for K2CO3-mediated C(aryl)-O bond formation

One-pot microwave-assisted tandem deprotection of arylmethanesulfonates / nucleophilic aromatic substitution reaction (SNAr) with activated aryl halides to synthesize asymmetrical diaryl ethers is described.

1-,2-,3-,4-,5-,6-,7-,8- AND/OR 9 SUBSTITUTED DIBENZOXAZEPINE COMPOUDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PAIN

The present invention provides substituted dibenzoxazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.